Start Date: 15/03/2018

End Date: 15/03/2018

Cost: 100/150

Venue: The Royal College of Physicians, London, NW1 4LE


The Royal Marsden NHS Foundation Trust

Contact Details:


With the rise of clinical genomics and digital imaging in mind, our latest symposium will provide an update on recent technological developments and their introduction into the diagnostic arena. The morning session will showcase applied research taking place in the Centre for Molecular Pathology (CMP) at our Sutton site, where these new approaches are driving forward clinical research across the oncological spectrum. The application of liquid biopsies for novel diagnostics fits the “hot topics” agenda. In the morning session you will hear from two leading clinical exponents of circulating tumour DNA (ctDNA) profiling on how the technique is enabling personalised treatment of cancer patients. The significant challenges – and opportunities – associated with this field is bound to trigger much discussion over lunch. The afternoon is themed by tumour type, with an outstanding faculty, all associated with the Centre for Molecular Pathology, describing how the latest clinical trials in their respective areas are being assisted by combining established methodologies with new technologies, including gene panel sequencing and digital droplet PCR. We will also hear how progress on Genomics England’s 100,000 genomes project is beginning to impact on cancer diagnostics. More and more doctors are facing the problem of how to handle the abundant data generated by genomic profiling. We will end the day with a live demonstration of a Molecular Tumour Board, in which somatic variants are discussed and placed in clinical context by a panel of experts and decisions are made on patient care. You are encouraged to join in the discussion. The meeting will engage and inform all health professionals and researchers interested in molecular diagnostics in cancer. The faculty will be available for lively discussion and debate between sessions.